Related Experiment Video
Updated: Aug 17, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan,
Masoud Etemadifar1, Amir Parsa Abhari2, Ghasem Yadegarfar3
1Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Pediatric-onset multiple sclerosis (POMS) shows a higher female-to-male ratio in Isfahan, Iran. The incidence of POMS is increasing, suggesting a need for more regionalized care for this central nervous system disorder.
Area of Science:
- Neurology
- Epidemiology
- Pediatrics
Background:
- Pediatric-onset multiple sclerosis (POMS) is a central nervous system (CNS) autoimmune demyelinating disorder affecting individuals under 18.
- Characterizing POMS epidemiology and clinical features is crucial for understanding disease trends.
Purpose of the Study:
- To determine the epidemiological and clinical characteristics of pediatric-onset multiple sclerosis (POMS) in Isfahan, Iran.
- To analyze temporal trends in POMS incidence and prevalence.
Main Methods:
- Retrospective review of medical records of POMS patients from April 1997 to March 2020.
- Utilized Isfahan Province population censuses for incidence and prevalence calculations.
- Employed Poisson regression to assess incidence rate trends.
Main Results:
- 509 POMS cases diagnosed; 79.4% were female, yielding a 3.85:1 female to male ratio.
- Most patients (83%) were monosymptomatic at onset, with optic neuritis and brainstem-cerebellar disorders being most common.
- A 3.4% annual increase in POMS incidence rate observed from April 1997 to March 2020.
Conclusions:
- The observed female to male ratio in POMS is significantly higher than previously reported.
- Increasing POMS incidence and high female predominance suggest potential regionalization of care needs.
- Further research into the factors driving these trends in pediatric multiple sclerosis is warranted.
Abstract:
Background: Pediatric-onset multiple sclerosis (POMS) is an autoimmune demyelinating disorder of the central nervous system (CNS), affecting individuals younger than 18 years of age. We sought to characterize the epidemiological and clinical features of patients with POMS in Isfahan, Iran, from April 1997 to March 2020. Methods: The medical records of patients with POMS in the databases of Isfahan Department of Public Health and Isfahan Multiple Sclerosis Society (IMSS) were retrospectively reviewed. The 2006 and 2016 Isfahan Province population censuses were used as reference values for assessing the temporal trend of POMS. Results: From April 1997 to March 2020, 509 individuals under18 years of age were diagnosed with POMS in Isfahan. 404 of these patients (79.4%) were girls, and 105 patients (20.6%) were boys (a female to male ratio of 3.85:1). Most of the patients (83%) were monosymptomatic at onset, with optic neuritis and brainstem-cerebellar disorders being the most frequent initial presentations. Mean ± standard deviation (SD) of age at disease diagnosis was 15.8 ± 2.5 years (ranging from 3 to 18, mode = 18). From April 2019 to March 2020, the crude prevalence and the crude incidence rate of the POMS were 5.42 per 100000 and 1.86 per 100000, respectively. Poisson regression analysis revealed a 3.4% increase in the incidence rate of POMS from April 1997 to March 2020 [relative rate:1.034, 95% confidence interval (CI): 1.021-1.048]. Conclusion: The female to male ratio in our cohort was significantly higher than any other studies conducted previously. The high female to male ratio and increasing incidence of the disease suggest increasing regionalization of care.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024